These Analysts Slash Their Forecasts On Equifax After Q2 Results

Benzinga Earnings
Jul 23

Equifax Inc. (NYSE:EFX) on Tuesday posted upbeat second-quarter results and issued third-quarter forecasts that came in below Wall Street expectations.

Adjusted earnings were $2.25 per share, topping the analyst consensus estimate of $2.20. Revenue rose 11% year over year to $1.70 billion, ahead of the $1.696 billion consensus estimate. On a local currency basis, revenue increased 10%.

Equifax narrowed its full-year adjusted EPS guidance to $8.39 to $8.69 from a previous range of $8.34 to $8.74. The midpoint remains in line with the analyst consensus estimate of $8.60.

The company also tightened its full-year revenue outlook to $6.71 billion-$6.78 billion from $6.685 billion-$6.805 billion. The midpoint is broadly in line with the consensus estimate of $6.764 billion.

For the third quarter, Equifax forecast adjusted EPS of $2.15 to $2.25, below the analyst estimate of $2.26. It expects revenue of $1.68 billion to $1.71 billion, compared with the consensus estimate of $1.711 billion.

Equifax shares fell 2.5% to trade at $168.72 on Wednesday.

These analysts made changes to their price targets on Equifax following earnings announcement.

  • Needham analyst Kyle Peterson maintained the stock with a Buy and lowered the price target from $265 to $245.
  • Barclays analyst Manav Patnaik maintained the stock with an Equal-Weight rating and cut the price target from $215 to $200.
  • RBC Capital analyst Ashish Sabadra maintained the stock with an Outperform rating and lowered the price target from $222 to $194.

Considering buying EFX stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10